Vitamin D and the skin: Physiology and pathophysiology

Reviews in Endocrine and Metabolic Disorders

Volumn 13, Issue 1, 2012, Pages 3-19

  Bikle, Daniel D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carcinogenesis; Co regulators; Differentiation; Epidermis; Hair follicle; Vitamin D

Indexed keywords

7 DEHYDROCHOLESTEROL; ALPHA CATENIN; BETA CATENIN; CALCITRIOL; CALCIUM ION; CYCLIN D1; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 14; CYTOKERATIN 5; FILAGGRIN; GLYCOGEN SYNTHASE KINASE 3BETA; INVOLUCRIN; KERATOHYALIN; LORICRIN; NUCLEAR RECEPTOR COACTIVATOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PHOSPHOLIPASE C GAMMA1; PROFILAGGRIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN P120; PROTEIN TYROSINE KINASE; SONIC HEDGEHOG PROTEIN; STEROID RECEPTOR COACTIVATOR 1; TOLL LIKE RECEPTOR 2; UVOMORULIN; VITAMIN D; VITAMIN D RECEPTOR; WNT PROTEIN;

ANTIPROLIFERATIVE ACTIVITY; ATOPIC DERMATITIS; BASAL CELL; BASEMENT MEMBRANE; CALCIUM HOMEOSTASIS; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; COMPLEX FORMATION; DERMIS; ENZYME ACTIVITY; EPIDERMIS; EPIDERMIS CELL; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENE TARGETING; GENOTOXICITY; HAIR FOLLICLE; HAIR GROWTH; HUMAN; INNATE IMMUNITY; KERATINOCYTE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SKIN; SKIN CANCER; SKIN PERMEABILITY; STEM CELL; STRATUM CORNEUM; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; VITAMIN D RESPONSIVE ELEMENT; VITAMIN METABOLISM;

ANIMALS; CELL DIFFERENTIATION; HUMANS; KERATINOCYTES; SKIN; VITAMIN D;

EID: 84858157622     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-011-9194-0     Document Type: Review

References (146)

1. Bikle DD, Pillai S. Vitamin D, calcium, and epidermal differentiation. Endocr Rev. 1993;14:3-19. (Pubitemid 23066529)
2. Tu CL, Chang W, Bikle DD. The extracellular calcium-sensing receptor is required for calcium- induced differentiation in human keratinocytes. J Biol Chem. 2001;276:41079-85.
3. Tu CL, Chang W, Bikle DD. Phospholipase cgamma1 is required for activation of store-operated channels in human keratinocytes. J Invest Dermatol. 2005;124:187-97. (Pubitemid 40100968)
4. Tu C, Chang W, Xie Z, Bikle D. Inactivation of the calcium sensing receptor inhibits E-cadherin-mediated cell-cell adhesion and calcium-induced differentiation in human epidermal keratinocytes. J Biol Chem. 2008;283:3519-28.
5. Xie Z, Singleton PA, Bourguignon LY, Bikle DD. Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol Biol Cell. 2005;16:3236-46. (Pubitemid 40962595)
6. Xie Z, Bikle DD. The recruitment of phosphatidylinositol 3- kinase to the E-cadherin-catenin complex at the plasma membrane is required for calcium-induced phospholipase C-gamma1 activation and human keratinocyte differentiation. J Biol Chem. 2007;282:8695-703. (Pubitemid 47093520)
7. Xie Z, Chang SM, Pennypacker SD, Liao EY, Bikle DD. Phosphatidylinositol- 4-phosphate 5-kinase 1alpha mediates extracellular calcium-induced keratinocyte differentiation. Mol Biol Cell. 2009;20:1695-704.
8. Yuspa SH, Kilkenny AE, Steinert PM, Roop DR. Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol. 1989;109:1207-17. (Pubitemid 19220102)
9. Hohl D. Cornified cell envelope. Dermatologica. 1990;180:201-11. (Pubitemid 20153879)
10. Thacher SM, Rice RH. Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell. 1985;40:685-95. (Pubitemid 15076584)
11. Hennings H, Steinert P, Buxman MM. Calcium induction of transglutaminase and the formation of epsilon(gamma-glutamyl) lysine cross-links in cultured mouse epidermal cells. Biochem Biophys Res Commun. 1981;102:739-45.
12. Menon GK, Grayson S, Elias PM. Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol. 1985;84:508-12. (Pubitemid 15053207)
13. Tu CL, Oda Y, Komuves L, Bikle DD. The role of the calcium-sensing receptor in epidermal differentiation. Cell Calcium. 2004;35:265-73. (Pubitemid 38292370)
14. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, et al. Cloning and characterization of an extracellular Ca-2+-sensing receptor from bovine parathyroid. Nature. 1993;366:575-80. (Pubitemid 24035999)
15. Oda Y, Tu CL, Pillai S, Bikle DD. The calcium sensing receptor and its alternatively spliced form in keratinocyte differentiation. J Biol Chem. 1998;273:23344-52. (Pubitemid 28417522)
16. Chang W, Tu C, Chen TH, Bikle D, Shoback D. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal. 2008;1:1-13.
17. Ratnam AV, Bikle DD, Cho JK. 1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes. J Cell Physiol. 1999;178:188-96. (Pubitemid 29034862)
18. Xie Z, Bikle DD. Cloning of the human phospholipase C-gamma1 promoter and identification of a DR6-type vitamin D-responsive element. J Biol Chem. 1997;272:6573-7. (Pubitemid 27118140)
19. Xie Z, Bikle DD. Phospholipase C-gamma1 is required for calcium-induced keratinocyte differentiation. J Biol Chem. 1999;274:20421-4.
20. Xie Z, Bikle DD. Inhibition of 1,25-Dihydroxyvitamin-D-Induced keratinocyte differentiation by blocking the expression of phospholipase C-gamma1. J Invest Dermatol. 2001;117:1250-4. (Pubitemid 34205925)
21. Su MJ, Bikle DD, Mancianti ML, Pillai S. 1,25-Dihydroxyvitamin D3 potentiates the keratinocyte response to calcium. J Biol Chem. 1994;269:14723-9.
22. Ng DC, Shafaee S, Lee D, Bikle DD. Requirement of an AP-1 site in the calcium response region of the involucrin promoter. J Biol Chem. 2000;275:24080-8.
23. Bikle DD, Ng D, Oda Y, Hanley K, Feingold K, Xie Z. The vitamin D response element of the involucrin gene mediates its regulation by 1,25-dihydroxyvitamin D3. J Invest Dermatol. 2002;119:1109-13. (Pubitemid 35430487)
24. Pillai S, Bikle DD. Role of intracellular-free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25 dihydroxyvitamin D3. J Cell Physiol. 1991;146:94-100. (Pubitemid 21910029)
25. Bikle DD, Pillai S, Gee E. Squamous carcinoma cell lines produce 1,25 dihydroxyvitamin D, but fail to respond to its prodifferentiating effect. J Invest Dermatol. 1991;97:435-41.
26. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T. Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25- dihydroxyvitamin D3. Endocrinology. 1983;113:1950-7. (Pubitemid 14213553)
27. Smith EL, Walworth NC, Holick MF. Effect of 1 alpha,25- dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol. 1986;86:709-14. (Pubitemid 16098227)
28. McLane JA, Katz M, Abdelkader N. Effect of 1,25-dihydroxyvitamin D3 on human keratinocytes grown under different culture conditions. In Vitro Cell Dev Biol. 1990;26:379-87. (Pubitemid 20179091)
29. Hawker NP, Pennypacker SD, Chang SM, Bikle DD. Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3. J Invest Dermatol. 2007;127:874.
30. Matsumoto K, Hashimoto K, Nishida Y, Hashiro M, Yoshikawa K. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun. 1990;166:916-23. (Pubitemid 20049933)
31. Bikle DD. The vitamin D receptor: a tumor suppressor in skin. Discov Med. 2011;11:7-17.
32. Oda Y, Uchida Y, Moradian S, Crumrine D, Elias P, Bikle D. Vitamin D receptor and coactivators SRC 2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J Invest Dermatol. 2009;129:1367-78.
33. Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007;117:803-11. (Pubitemid 46348539)
34. Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology. 2006;118:509-19. (Pubitemid 44079569)
35. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA. 1997;94:9831-5.
36. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16:391-6. (Pubitemid 27323308)
37. Malloy PJ, Pike JW, Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev. 1999;20:156-88. (Pubitemid 29341671)
38. Xie Z, Komuves L, Yu QC, Elalieh H, Ng DC, Leary C, et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol. 2002;118:11-6. (Pubitemid 34107418)
39. Bikle DD, Elalieh H, Chang S, Xie Z, Sundberg JP. Development and progression of alopecia in the vitamin D receptor null mouse. J Cell Physiol. 2006;207:340-53.
40. Teichert A, Elalieh H, Bikle D. Disruption of the hedgehog signaling pathway contributes to the hair follicle cycling deficiency in Vdr knockout mice. J Cell Physiol. 2010;225:482-9.
41. Bikle DD, Chang S, Crumrine D, Elalieh H, Man MQ, Choi EH, et al. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol. 2004;122:984-92. (Pubitemid 38581001)
42. Muehleisen B, Bikle D, Gallo RL. Interplay of vitamin D and innate immune responses affects bacterial skin infection. J Invest Dermatol. 2011;131:S1-S141. Abstracts #631.
43. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science. 2002;296:1313-6. (Pubitemid 34522785)
44. Peric M, Koglin S, Dombrowski Y, Gross K, Bradac E, Ruzicka T, et al. VDR and MEK-ERK dependent induction of the antimicrobial peptide cathelicidin in keratinocytes by lithocholic acid. Mol Immunol. 2009;46:3183-7.
45. Zbytek B, Janjetovic Z, Tuckey RC, Zmijewski MA, Sweatman TW, Jones E, et al. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol. 2008;128:2271-80.
46. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin d(3)- 1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86:888-94.
47. Milde P, Hauser U, Simon T, Mall G, Ernst V, Haussler MR, et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol. 1991;97:230-9.
48. Stumpf WE, Clark SA, Sar M, DeLuca HF. Topographical and developmental studies on target sites of 1,25 (OH)2 vitamin D3 in skin. Cell Tissue Res. 1984;238:489-96. (Pubitemid 15190650)
49. Oda Y, Sihlbom C, Chalkley RJ, Huang L, Rachez C, Chang CP, et al. Two distinct coactivators, DRIP/mediator and SRC/ p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation. Mol Endocrinol. 2003;17:2329-39. (Pubitemid 37352542)
50. McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999;20:321-44. (Pubitemid 30649811)
51. Oda Y, Ishikawa MH, Hawker NP, Yun QC, Bikle DD. Differential role of two VDR coactivators, DRIP205 and SRC-3, in keratinocyte proliferation and differentiation. J Steroid Biochem Mol Biol. 2007;103:776-80. (Pubitemid 46401337)
52. Schauber J, Oda Y, Buchau AS, Steinmeyer A, Zugel U, Bikle DD, et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. J Invest Dermatol. 2008;128:816-24. (Pubitemid 351374298)
53. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature. 1999;398:824-8.
54. Rachez C, GambleM, Chang CP, Atkins GB, LazarMA, Freedman LP. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol Cell Biol. 2000;20:2718-26. (Pubitemid 30183490)
55. Leo C, Chen JD. The SRC family of nuclear receptor coactivators. Genes. 2000;245:1-11. (Pubitemid 30125358)
56. Teichert A, Arnold LA, Otieno S, Oda Y, Augustinaite I, Geistlinger TR, et al. Quantification of the vitamin D receptor-coregulator interaction. Biochemistry. 2009;48:1454-61.
57. Acevedo ML, Lee KC, Stender JD, Katzenellenbogen BS, Kraus WL. Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain. Mol Cell. 2004;13:725-38. (Pubitemid 38368129)
58. Christakos S, Dhawan P, Liu Y, Peng X, Porta A. New insights into the mechanisms of vitamin D action. J Cell Biochem. 2003;88:695-705. (Pubitemid 36258819)
59. Rachez C, Freedman LP. Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene. 2000;246:9-21. (Pubitemid 30190157)
60. Carvallo L, Henriquez B, Paredes R, Olate J, Onate S, Van Wijnen AJ, et al. 1,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex. J Cell Physiol. 2008;214:740-9. (Pubitemid 351224219)
61. Issa LL, Leong GM, Sutherland RL, Eisman JA. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators. J Bone Miner Res. 2002;17:879-90. (Pubitemid 34441905)
62. Bouillon R, Verlinden L, Eelen G, De Clercq P, Vandewalle M, Mathieu C, et al. Mechanisms for the selective action of vitamin D analogs. J Steroid Biochem Mol Biol. 2005;97:21-30. (Pubitemid 41546210)
63. Maeda Y, Rachez C, Hawel IL, Byus CV, Freedman LP, Sladek FM. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205. Mol Endocrinol. 2002;16:1502-10. (Pubitemid 34743670)
64. Peleg S, Ismail A, Uskokovic M, Avnur Z. Evidence for tissue-and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3. J Cell Biochem. 2003;88:267-73. (Pubitemid 36119897)
65. Schauber J, Oda Y, Buchau AS, Yun QC, Steinmeyer A, Zugel U, et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-Dihydroxyvitamin D(3). J Invest Dermatol. 2008;128:816-24. (Pubitemid 351374298)
66. Bikle DD, Teichert A, Arnold LA, Uchida Y, Elias PM, Oda Y. Differential regulation of epidermal function by VDR coactivators. J Steroid Biochem Mol Biol. 2010;121:308-13.
67. Beaudoin III GM, Sisk JM, Coulombe PA, Thompson CC. Hairless triggers reactivation of hair growth by promoting Wnt signaling. Proc Natl Acad Sci USA. 2005;102:14653-8. (Pubitemid 41457111)
68. Djabali K, Aita VM, Christiano AM. Hairless is translocated to the nucleus via a novel bipartite nuclear localization signal and is associated with the nuclear matrix. J Cell Sci. 2001;114:367-76. (Pubitemid 32149578)
69. Liu L, Kim H, Casta A, Luke C, Kobayashi Y, Shapiro LS, et al. Hairless is a H3K9 histone demethylase. J Invest Dermatol. 2011;131:S1-S141. S169, #409.
70. Thompson CC, Bottcher MC. The product of a thyroid hormone-responsive gene interacts with thyroid hormone receptors. Proc Natl Acad Sci USA. 1997;94:8527-32. (Pubitemid 27335072)
71. Engelhard A, Christiano AM. The hairless promoter is differentially regulated by thyroid hormone in keratinocytes and neuroblastoma cells. Exp Dermatol. 2004;13:257-64. (Pubitemid 38618082)
72. Xie Z, Chang S, Oda Y, Bikle DD. Hairless suppresses vitamin D receptor transactivation in human keratinocytes. Endocrinology. 2006;147:314-23. (Pubitemid 43004285)
73. Hsieh JC, Sisk JM, Jurutka PW, Haussler CA, Slater SA, Haussler MR, et al. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J Biol Chem. 2003;278:38665-74. (Pubitemid 37229065)
74. Zarach JM, Beaudoin 3rd GM, Coulombe PA, Thompson CC. The co-repressor hairless has a role in epithelial cell differentiation in the skin. Development. 2004;131:4189-200. (Pubitemid 39276189)
75. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509-12. (Pubitemid 28425575)
76. Bienz M. beta-Catenin: a pivot between cell adhesion and Wnt signalling. Curr Biol. 2005;15:R64-67.
77. Chan EF, Gat U, McNiff JM, Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet. 1999;21:410-3. (Pubitemid 29159579)
78. Gat U, DasGupta R, Degenstein L, Fuchs E. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell. 1998;95:605-14. (Pubitemid 28544122)
79. Xia J, Urabe K, Moroi Y, Koga T, Duan H, Li Y, et al. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas. J Dermatol Sci. 2006;41:67-75. (Pubitemid 43075433)
80. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001;154:369-87. (Pubitemid 34286147)
81. Shah S, Hecht A, Pestell R, Byers SW. Trans-repression of beta-catenin activity by nuclear receptors. J Biol Chem. 2003;278:48137-45. (Pubitemid 37523266)
82. Teichert A, Elalieh H, Elias P, Welsh J, Bikle D. Over-expression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor null mice. J Invest Dermatol. (in press)2011.
83. Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, et al. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell. 2006;21:799-809. (Pubitemid 43376130)
84. Palmer HG, Anjos-Afonso F, Carmeliet G, Takeda H, Watt FM. The vitamin D receptor is a Wnt Effector that controls hair follicle differentiation and specifies tumor type in adult epidermis. PLoS ONE. 2008;3:e1483.
85. Cianferotti L, Cox M, Skorija K, Demay MB. Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc Natl Acad Sci USA. 2007;104:9428-33. (Pubitemid 47185796)
86. Shimizu H, Morgan BA. Wnt signaling through the beta-catenin pathway is sufficient to maintain, but not restore, anagen-phase characteristics of dermal papilla cells. J Invest Dermatol. 2004;122:239-45. (Pubitemid 38281040)
87. Kishimoto J, Burgeson RE, Morgan BA. Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev. 2000;14:1181-5. (Pubitemid 30327499)
88. Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S, et al. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol. 2004;22:411-7. (Pubitemid 38451371)
89. Langbein L, Rogers MA, Praetzel S, Winter H, Schweizer J. K6irs1, K6irs2, K6irs3, and K6irs4 represent the inner-root-sheath- specific type II epithelial keratins of the human hair follicle. J Invest Dermatol. 2003;120:512-22. (Pubitemid 36343992)
90. Zhou P, Byrne C, Jacobs J, Fuchs E. Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes Dev. 1995;9:700-13.
91. Hochberg Z, Gilhar A, Haim S, Friedman-Birnbaum R, Levy J, Benderly A. Calcitriol-resistant rickets with alopecia. Arch Dermatol. 1985;121:646-7. (Pubitemid 15062719)
92. Marx SJ, Bliziotes MM, Nanes M. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol (Oxf). 1986;25:373-81. (Pubitemid 16031774)
93. Sakai Y, Demay MB. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. Endocrinology. 2000;141:2043-9. (Pubitemid 32274354)
94. Kong J, Li XJ, Gavin D, Jiang Y, Li YC. Targeted expression of human vitamin d receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. J Invest Dermatol. 2002;118:631-8. (Pubitemid 34309982)
95. Chen CH, Sakai Y, DemayMB. Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. Endocrinology. 2001;142:5386-9. (Pubitemid 33131972)
96. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology. 1998;139:4391-6. (Pubitemid 28513729)
97. Teichert A, Elalieh H, Bikle D. Role of vitamin D receptor in hair follicle cycling through local expression. J Invest Dermatol. 2011;131:S1-S141. Abstract #446.
98. Panteleyev AA, Botchkareva NV, Sundberg JP, Christiano AM, Paus R. The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol. 1999;155:159-71. (Pubitemid 29318714)
99. Miller J, Djabali K, Chen T, Liu Y, Ioffreda M, Lyle S, et al. Atrichia caused by mutations in the vitamin D receptor gene is a phenocopy of generalized atrichia caused by mutations in the hairless gene. J Invest Dermatol. 2001;117:612-7. (Pubitemid 32955588)
100. Ahmad W, Faiyaz ul Haque M, Brancolini V, Tsou HC, ul Haque S, Lam H, et al. Alopecia universalis associated with a mutation in the human hairless gene. Science. 1998;279:720-4.
101. Millar SE. Molecular mechanisms regulating hair follicle development. J Invest Dermatol. 2002;118:216-25. (Pubitemid 34158473)
102. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev. 2001;81:449-94. (Pubitemid 32096181)
103. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W. beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell. 2001;105:533-45. (Pubitemid 32520858)
104. DasGupta R, Rhee H, Fuchs E. A developmental conundrum: a stabilized form of beta-catenin lacking the transcriptional activation domain triggers features of hair cell fate in epidermal cells and epidermal cell fate in hair follicle cells. J Cell Biol. 2002;158:331-44.
105. Chiang C, Swan RZ, Grachtchouk M, Bolinger M, Litingtung Y, Robertson EK, et al. Essential role for Sonic hedgehog during hair follicle morphogenesis. Dev Biol. 1999;205:1-9. (Pubitemid 29042654)
106. Reddy ST, Andl T, Lu MM, Morrisey EE, Millar SE. Expression of Frizzled genes in developing and postnatal hair follicles. J Invest Dermatol. 2004;123:275-82. (Pubitemid 38951820)
107. Luderer HF, Gori F, Demay MB. Lymphoid enhancer-binding factor-1 (LEF1) interacts the DNA-binding domain of the vitamin D receptor. J Biol Chem. 2011;286:18444-51.
108. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36. (Pubitemid 32166444)
109. Freeman SE, Hacham H, Gange RW, Maytum DJ, Sutherland JC, Sutherland BM. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci USA. 1989;86:5605-9. (Pubitemid 19185593)
110. Hussein MR. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol. 2005;32:191-205. (Pubitemid 40278816)
111. Daya-Grosjean L, Sarasin A. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res. 2005;571:43-56. (Pubitemid 40313431)
112. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA. 1993;90:4216-20. (Pubitemid 23134197)
113. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, et al. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372:773-6.
114. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA. 1991;88:10124-8. (Pubitemid 21915787)
115. Bito T, Ueda M, Ahmed NU, Nagano T, Ichihashi M. Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression. J Cutan Pathol. 1995;22:427-34.
116. Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol. 2005;152:43-51.
117. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996;272:1668-71. (Pubitemid 26200029)
118. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 1996;85:841-51. (Pubitemid 26192135)
119. Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, Bonifas JM, et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol. 1998;110:885-8. (Pubitemid 28237693)
120. Aszterbaum M, Epstein J, Oro A, Douglas V, LeBoit PE, Scott MP, et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med. 1999;5:1285-91. (Pubitemid 29535606)
121. Ping XL, Ratner D, Zhang H, Wu XL, Zhang MJ, Chen FF, et al. PTCH mutations in squamous cell carcinoma of the skin. J Invest Dermatol. 2001;116:614-6. (Pubitemid 32299854)
122. Grachtchouk M, Pero J, Yang SH, Ermilov AN, Michael LE, Wang A, et al. Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations. J Clin Invest. 2011;121:1768-81.
123. Zinser GM, Sundberg JP, Welsh J. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis. 2002;23:2103-9. (Pubitemid 36109123)
124. Indra AK, Castaneda E, Antal MC, Jiang M, Messaddeq N, Meng X, Loehr CV, Gariglio P, Kato S, Wahli W, Desvergne B, Metzger D, Chambon P. Malignant transformation of DMBA/ TPA-Induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes. J Invest Dermatol. 2007.
125. Ellison TI, Smith MK, Gilliam AC, Macdonald PN. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-Induced tumorigenesis. J Invest Dermatol. 2008;128:2508-17.
126. Dixon KM, Deo SS, Wong G, Slater M, Norman AW, Bishop JE, et al. Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol. 2005;97:137-43. (Pubitemid 41546223)
127. Gupta R, Dixon KM, Deo SS, Holliday CJ, Slater M, Halliday GM, et al. Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol. 2007;127:707-15.
128. De Haes P, Garmyn M, Degreef H, Vantieghem K, Bouillon R, Segaert S. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem. 2003;89:663-73. (Pubitemid 36759128)
129. Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Ikram MS, et al. The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells. Oncogene. 2004;23:1263-74. (Pubitemid 38297181)
130. Barnfield PC, Zhang X, Thanabalasingham V, Yoshida M, Hui CC. Negative regulation of Gli1 and Gli2 activator function by suppressor of fused through multiple mechanisms. Differentiation. 2005;73:397-405. (Pubitemid 43922158)
131. Wakabayashi Y, Mao JH, Brown K, Girardi M, Balmain A. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature. 2007;445:761-5. (Pubitemid 46279707)
132. Bijlsma MF, Spek CA, Zivkovic D, van de Water S, Rezaee F, Peppelenbosch MP. Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol. 2006;4: e232.
133. Tang JY, Xiao TZ, Oda Y, Chang KS, Shpall E, Wu A, et al. Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas. Canc Prev Res (Philadelphia, Pa). 2011;4:744-51.
134. Svard J, Heby-Henricson K, Persson-Lek M, Rozell B, Lauth M, Bergstrom A, et al. Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev Cell. 2006;10:187-97. (Pubitemid 43174952)
135. Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 2004;64:7724-31. (Pubitemid 39446903)
136. Regl G, Neill GW, Eichberger T, Kasper M, Ikram MS, Koller J, et al. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma. Oncogene. 2002;21:5529-39. (Pubitemid 34983542)
137. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, Hui CC, et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet. 2000;24:216-7. (Pubitemid 30132187)
138. Nilsson M, Unden AB, Krause D, Malmqwist U, Raza K, Zaphiropoulos PG, et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci USA. 2000;97:3438-43. (Pubitemid 30183321)
139. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein Jr EH, Scott MP. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science. 1997;276:817-21. (Pubitemid 27199865)
140. Fan H, Oro AE, Scott MP, Khavari PA. Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat Med. 1997;3:788-92.
141. Tojo M, Mori T, Kiyosawa H, Honma Y, Tanno Y, Kanazawa KY, et al. Expression of sonic hedgehog signal transducers, patched and smoothened, in human basal cell carcinoma. Pathol Int. 1999;49:687-94. (Pubitemid 29503464)
142. Bonifas JM, Pennypacker S, Chuang PT, McMahon AP, Williams M, Rosenthal A, et al. Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol. 2001;116:739-42. (Pubitemid 32467653)
143. Eichberger T, Regl G, Ikram MS, Neill GW, Philpott MP, Aberger F, et al. FOXE1, a new transcriptional target of GLI2 is expressed in human epidermis and basal cell carcinoma. J Invest Dermatol. 2004;122:1180-7. (Pubitemid 38651093)
144. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005;19:2685-95. (Pubitemid 41577243)
145. Saldanha G, Ghura V, Potter L, Fletcher A. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Br J Dermatol. 2004;151:157-64. (Pubitemid 39061293)
146. Iwatsuki K, Liu HX, Gronder A, Singer MA, Lane TF, Grosschedl R, et al. Wnt signaling interacts with Shh to regulate taste papilla development. Proc Natl Acad Sci USA. 2007;104:2253-8. (Pubitemid 46391384)